- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI Summary - About
Shimadzu Corp(SHMXY)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for SHMXY
11/13/2026: SHMXY (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Shimadzu Corporation is a well-established Japanese manufacturer of analytical, medical, and industrial precision instruments. The company benefits from a strong reputation in scientific research and a diversified revenue model that spans global laboratory and clinical healthcare markets. Its primary growth opportunity lies in increasing the automation of complex laboratory workflows and expanding its reach in emerging healthcare markets. However, the company faces significant competitive pressure from larger global peers and potential exposure to currency volatility. It is a stable, long-term focused stock that may best suit value-oriented or conservative investors looking for steady, research-backed industrial exposure, with key developments in clinical diagnostics and R&D spend worth monitoring.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | Growth is steady and reliable rather than rapid, appealing to those seeking long-term compounders. |
| Momentum investor | Weak fit | The stock tends to follow long-term cycles rather than exhibiting high-frequency momentum signals. |
| Value investor | Strong fit | Often trades at valuation levels that value investors find attractive relative to its fundamental quality. |
| Dividend investor | Strong fit | Provides a reliable income stream, making it suitable for income-focused portfolios. |
| Low-risk investor | Strong fit | The company's stable business model and long history provide a degree of comfort for risk-averse investors. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium | The stock is subject to currency risks and broader Japanese market fluctuations. |
| Valuation risk | Low | Current valuations generally reflect stable fundamental performance. |
| Competition risk (Instrumentation) | Medium / high | Competition from larger players like Thermo Fisher can pressure margins. |
| Business quality | Strong | High technical barriers to entry support the company's long-term franchise value. |
| Dividend income | Medium | Dividends are reliable but not high-yield compared to specialized income stocks. |
| Execution risk | Medium | Successful integration of new technology into global markets is critical for growth. |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 8.39B USD | Price to earnings Ratio 20.18 | 1Y Target Price - |
Price to earnings Ratio 20.18 | 1Y Target Price - | ||
Volume (30-day avg) 7.7K shares | Beta 0.74 | 52 Weeks Range 10.41 - 16.77 | Updated Date 11/14/2026 |
52 Weeks Range 10.41 - 16.77 | Updated Date 11/14/2026 | ||
Dividends yield (FY) 1.49% | Basic EPS (TTM) 0.72 |
Sector & Industry Intelligence
Sector
Technology
Caution- Sentiment
- Near Bearish
- Momentum
- Rapid Breadth Deterioration
- BUY participation
- 30.1%
- Active BUY / eligible
- 37 / 123
- 30-Day BUY Count Change
- -42
- Market state
- Weak Bullish / Near Bearish
BUY participation is falling rapidly, suggesting elevated market vulnerability.
Industry
Scientific & Technical Instruments
- BUY participation
- 0.0%
- Active BUY / eligible
- 0 / 4
- 30-Day BUY Count Change
- -2
Eligible universe: 4 stocks.
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.

Highly Choppy
The stock has experienced frequent, large price swings that make its near-term movement less predictable.
Analysis of Past Performance
Type Stock | Historic Profit -37.82% | Avg. Invested days 26 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Analytical Instruments | LC-MS, Gas Chromatographs, and other testing equipment for research labs. | This is the core profit driver, fueled by ongoing global R&D spending. |
| Medical Systems | X-ray and diagnostic imaging machines for clinics. | Provides a stable, essential healthcare revenue stream. |
| Geography (Japan) | Sales within the domestic Japanese market. | A significant revenue base that provides stability but limits geographic diversification. |
Valuation
Trailing PE 20.18 | Forward PE - | Enterprise Value 8.21B | Price to Sales(TTM) 0.01 |
Enterprise Value 8.21B | Price to Sales(TTM) 0.01 | ||
Enterprise Value to Revenue 2.24 | Enterprise Value to EBITDA 11.85 | Shares Outstanding 577.63M | Shares Floating 576.28M |
Shares Outstanding 577.63M | Shares Floating 576.28M | ||
Percent Insiders - | Percent Institutions - |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

